Testing chemotherapy efficacy in HER2 negative breast cancer using patient-derived spheroids

BACKGROUND: Targeted anti-HER2 therapy has greatly improved the prognosis for many breast cancer patients. However, treatment for HER2 negative disease is currently still selected from a multitude of untargeted chemotherapeutic treatment options. A predictive test was developed using patient-derived...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:J Transl Med
Auteurs principaux: Halfter, Kathrin, Hoffmann, Oliver, Ditsch, Nina, Ahne, Mareike, Arnold, Frank, Paepke, Stefan, Grab, Dieter, Bauerfeind, Ingo, Mayer, Barbara
Format: Artigo
Langue:Inglês
Publié: BioMed Central 2016
Sujets:
Research
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC4855689/
https://ncbi.nlm.nih.gov/pubmed/27142386
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12967-016-0855-3
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires